9 terminated. 9 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Terminated 9 |
Follow Bipolar Disorder: new trials by email Literature Review of Bipolar Disorder trials Research Report on Bipolar Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alexithymia Intervention for Suicide Affective Awareness - Suicide, Schizophrenia | Phase 1 | Terminated | VA Office of Research and Development | 11 | 2023-10-01 | 2026-03-27 |
| Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder 4 mg Delta-9-THC, Placebo, 2 mg Delta-9-THC - Delta-9-Tetrahydroncannabinol, Bipolar Disorder | Phase 1 | Terminated | Yale University | 2 | 2017-08-01 | 2022-01-31 |
| Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations Syntocinon 24 Intranasal Units (IU), Syntocinon 40 Intranasal Units (IU), Intranasal Placebo - Borderline Personality Disorder, BPD | Phase 1 | Terminated | Maria de las Mercedes Perez Rodriguez | 92 | 2013-09-01 | 2022-10-10 |
| Positron Emission Tomography (PET) Imaging of Glial Activation in Psychotic Disease States [11C]DPA-713 - Schizophrenia, Bipolar Disorder | Phase 1 | Terminated | Johns Hopkins University | 35 | 2010-08-01 | 2020-09-10 |
| A Study Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET (Positron Emission Tomography) PF-04455242 - Bipolar Disorder, Depression | Phase 1 | Terminated | Pfizer | 12 | 2009-09-01 | 2010-02-08 |
| A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects Placebo, Vofopitant, Lamotrigine - Bipolar Disorder | Phase 1 | Terminated | GlaxoSmithKline | 12 | 2009-05-15 | 2017-07-21 |
| Oral Contraceptive Interaction Study for GW273225 GW273225, COC - Bipolar Disorder | Phase 1 | Terminated | GlaxoSmithKline | 12 | 2007-03-07 | 2017-08-08 |
| Treatment Resistant Bipolar Depression Escitalopram, placebo - Bipolar Depression | Phase 1 | Terminated | Queen's University | 1 | 2006-10-01 | 2015-12-16 |
| Taurine in Adolescents With Bipolar Disorder Taurine - Bipolar Disorder | Phase 1 | Terminated | Cambridge Health Alliance | 4 | 2006-02-01 | 2010-02-03 |
Schizophrenia (3) · Autism Spectrum Disorder (1) · Borderline Personality Disorder (1) · Depression (1) · Depressive Disorder, Major (1) · Mania (1) · Psychotic Disorders (1) · Schizotypal Personality Disorder (1) · Stress Disorders, Post-Traumatic (1) · Suicide (1)
Bipolar and Related Disorders (9) · Mental Disorders (9) · Mood Disorders (9) · Schizophrenia Spectrum and Other Psychotic Disorders (3) · Behavior (2) · Behavioral Symptoms (2) · Child Development Disorders, Pervasive (1) · Depressive Disorder (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurodevelopmental Disorders (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Personality Disorders (1) · Self-Injurious Behavior (1)
2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (1) · Dexetimide (1) · Dronabinol (1) · Escitalopram (1) · Lamotrigine (1) · Taurine (1) · vofopitant (1)
GlaxoSmithKline (2) · Cambridge Health Alliance (1) · Johns Hopkins University (1) · Maria de las Mercedes Perez Rodriguez (1) · Pfizer (1) · Queen's University (1) · VA Office of Research and Development (1) · Yale University (1)
United States (6) · Canada (1) · Germany (1) · United Kingdom (1)
Jean Frazier, MD (1) · Marianne S. Goodman, MD (1) · Martin Pomper, MD,PhD (1) · Mohini Ranganathan, MD (1) · Roumen V. Milev, MD (1)
UL1TR000067 (1)